Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality.
Olender SA, Walunas TL, Martinez E, Perez KK, Castagna A, Wang S, Kurbegov D, Goyal P, Ripamonti D, Balani B, De Rosa FG, De Wit S, Kim SW, Diaz G, Bruno R, Mullane KM, Lye DC, Gottlieb RL, Haubrich RH, Chokkalingam AP, Wu G, Diaz-Cuervo H, Brainard DM, Lee IH, Hu H, Lin L, Osinusi AO, Bernardino JI, Boffito M.
Olender SA, et al. Among authors: wu g.
Open Forum Infect Dis. 2021 May 26;8(7):ofab278. doi: 10.1093/ofid/ofab278. eCollection 2021 Jul.
Open Forum Infect Dis. 2021.
PMID: 34282406
Free PMC article.